Losing participants before the trial ends erodes credibility of findings

Psychiatric Bulletin

Volumn 33, Issue 7, 2009, Pages 254-257

  Xia, Jun ^a   Adams, Clive ^b   Bhagat, Nishant ^c   Bhagat, Vinaya ^c   Bhoopathi, Paranthaman ^c   El Sayeh, Hany ^c   Pinfold, Vanessa ^d   Takriti, Yahya ^c  

^a Bridge House ^*  (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Department of Old Age Psychiatry   (United Kingdom)

^d Rethink   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ARTICLE; CAREGIVER; CLINICAL STUDY; DRUG SCREENING; FOLLOW UP; HUMAN; MENTAL HEALTH SERVICE; METHODOLOGY; NORMAL HUMAN; PARTICIPANT OBSERVATION; PERSONNEL; PHYSICIAN; QUESTIONNAIRE; RESEARCH SUBJECT; SAMPLE SIZE; SCHIZOPHRENIA; TRUST;

EID: 67650789837     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.bp.108.021949     Document Type: Article

References (10)

1. Cure SJ, Adams CE. Forensic trials inform the present and future. Br J Psychiatry 2000; 177: 182. (Pubitemid 30624838)
2. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998; 317: 1181-1184
3. Hollis S, Campbell, F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319: 670-674 (Pubitemid 29423954)
4. Dunn G, Maracy M, Tomenson B. Estimating treatment effects from randomised clinical trials with non-compliance and loss to follow-up: the role of instrumental variable methods. Stat Methods Med Res 2005; 14: 369-395 (Pubitemid 41300812)
5. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF? Schizophr Bull 2007; 33: 183-91.
6. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizo-phrenia. Br J Psychiatry 2000; 176: 249-252
7. WHO Scientific Group on Treatment of Psychiatric Disorders. Evaluation of Methods for the Treatment of Mental Disorders. World Health Organization, 1991.
8. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patientswith chronic schizophrenia. N Engl J Med 2005; 353: 1209-1223
9. Cotton SM, Yuen HP, Berger G, McGorry P. Last observation carried forward in psychiatric research - a flawed gold standard. Aust N Z J Psychiatry 2005; 39: 622.
10. Bain MRS, Chalmers JWT, Brewster DH. Routinely collected data in national and regional databases - an underused resource. J Public Health Med 1997; 19: 413-418